Email Updates

You are here

Home»Media

AVAC in the News

  • Studies Support Truvada as Prevention

    A range of antiretroviral based prevention trials released data providing strong new evidence for how well daily oral pre-exposure prophylaxis (PrEP) work to prevent new HIV infections. The studies were presented at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI).

    February 26, 2015
    PrEP
    Voice of America

  • HIV Drugs Shown to Be Effective in Trials

    Findings from several clinical trials show how well drugs meant to treat the AIDS virus can protect people from becoming infected. But the trials also show that finding prevention methods that people will use is just as important as the medications themselves.

    February 24, 2015
    PrEP
    Wall Street Journal

  • Study That Paid Patients to Take HIV Drugs Fails

    Financial incentives do not have a significant effect on HIV drug adherence.

    February 24, 2015
    Microbicides
    The New York Times

  • Failure of Anti-HIV Gel Shows Difficulty of Prevention

    A vaginal gel containing Gilead Sciences Inc.’s HIV drug Viread, which has shown promise at preventing infections in past tests, was ineffective when used by at-risk women in South Africa, a study found.

    February 24, 2015
    Microbicides
    Bloomberg Business

  • Critiquing UNAIDS HIV Prevention Goals, AVAC Calls For Honed Strategy

    The global HIV advocacy group AVAC has raised an alarm that global goals for HIV prevention may prove ineffectual due to their vagueness. In a comprehensive report on the state of the HIV epidemic, AVAC has called for more specific targets that harness scientific knowhow in order to deliver reasonable results along a set timeline.

    February 23, 2015
    AIDSMeds

  • With future of HIV prevention "on the line," AVAC calls for sharper, bolder strategy to end the epidemic

    In a report issued today, AVAC warned that global HIV prevention efforts are in jeopardy due to an absence of strategic targets, resources and specific implementation plans to translate science, slogans and goals into action. The report calls for a robust set of global HIV prevention targets tailored to specific interventions and demands action in several key areas of the global AIDS response, including expanded rollout of daily oral pre-exposure prophylaxis, or PrEP, and alignment of science and human rights-based agendas.

    February 19, 2015
    PR Newswire

  • Overcoming HIV Obstacles in 2015

    The head of a prominent HIV/AIDS advocacy organization says 2015 will be a year of great opportunities and great challenges.

    January 1, 2015
    General
    Voice of America

  • Ending AIDS Requires Strategy, Funding

    UNAIDS has set a goal of ending the epidemic by 2030 but a strategic plan and much funding are needed to achieve that goal.

    December 1, 2014
    Combination Prevention
    Voice of America

  • CDC: Most Americans who need HIV treatment aren't getting it

    About 1.2 million Americans have HIV. Most of them know that they’re positive—only 14 percent are undiagnosed. But among those who know their status, fewer than half get care, according to new data from the Centers for Disease Control.

    December 1, 2014
    Treatment
    Bloomberg Businessweek

  • We Can't Wait Five Years to See if the AIDS Response is on Track

    UNAIDS' recent global goals offer a meaningful vision of what the "end of AIDS" might really mean. Now it's time to sit down, roll up our sleeves, write the plan to achieve them — and implement at scale, with increased pace and with urgency.

    November 26, 2014
    General
    Huffington Post

Pages